Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence
Katarzyna Korzeniowska, Jerzy Jankowski, Artur Cieślewicz, Anna Jabłecka Department of Clinical Pharmacology, Poznan University of Medical Sciences, Poznan 61-848, PolandCorrespondence: Artur CieślewiczDepartment of Clinical Pharmacology, Poznan University of Medical Sciences, Długa 1/2 Str., Poznan...
Saved in:
Main Authors: | Korzeniowska K (Author), Jankowski J (Author), Cieślewicz A (Author), Jabłecka A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Photosensitivity reactions in the elderly population: questionnaire-based survey and literature review
by: Korzeniowska K, et al.
Published: (2019) -
Trilogy of drug repurposing for developing cancer and chemotherapy-induced heart failure co-therapy agent
by: Xin Chen, et al.
Published: (2024) -
Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap
by: Conti N, et al.
Published: (2021) -
Underlying mechanisms of ketotherapy in heart failure: current evidence for clinical implementations
by: Kun Liu, et al.
Published: (2024) -
THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE
by: S. N. Tereshchenko, et al.
Published: (2015)